Literature DB >> 11682624

Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms.

M H Faulds1, K Pettersson, J A Gustafsson, L A Haldosén.   

Abstract

Steroid hormone receptors and signal transducers and activators of transcription (STAT) factors constitute two distinct families of transcription factors activated by different signaling pathways. In previous reports, cross-talk between STAT5 and several steroid receptors has been demonstrated. We investigated putative cross-talk between ERalpha and ERbeta and STAT5. ERalpha and ERbeta were found to potently repress PRL-induced STAT5 transcriptional activity on a beta-casein promoter construct in a ligand-dependent manner. This down-regulation was found to rely on direct physical interaction between the ERs and STAT5, mediated via the ER DNA-binding domain (DBD). The contact between the ER DBD and STAT5 is highly specific; the interaction is abolished if the ERalpha DBD is replaced with the DBD of a closely related steroid receptor. The physical interaction, however, is insufficient to confer the repression of STAT5 activity, which in addition requires the ligand-activated C-terminal part of the ERs, although these domains are not in direct contact with STAT5. Negative cross-talk between ERs and STAT5 is thus mediated via several functionally separated domains of the ERs. Our findings may enhance the understanding of mechanisms of regulation of the different hormonal signaling pathways occurring during different functional events in tissues coexpressing ERs and STAT5.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682624     DOI: 10.1210/mend.15.11.0726

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  27 in total

1.  Disrupting actions of bisphenol A and malachite green on growth hormone receptor gene expression and signal transduction in seabream.

Authors:  Baowei Jiao; Christopher H K Cheng
Journal:  Fish Physiol Biochem       Date:  2008-05-28       Impact factor: 2.794

Review 2.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 3.  Minireview: Estrogen receptor-beta: mechanistic insights from recent studies.

Authors:  Bonnie J Deroo; Adrian V Buensuceso
Journal:  Mol Endocrinol       Date:  2010-04-02

Review 4.  STAT signaling in mammary gland differentiation, cell survival and tumorigenesis.

Authors:  S Haricharan; Y Li
Journal:  Mol Cell Endocrinol       Date:  2013-03-28       Impact factor: 4.102

5.  Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Authors:  Anne M Miermont; Angela R Parrish; Priscilla A Furth
Journal:  Carcinogenesis       Date:  2010-02-24       Impact factor: 4.944

6.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

Review 7.  Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

Authors:  Emily M Fox; Josefa Andrade; Margaret A Shupnik
Journal:  Steroids       Date:  2008-11-05       Impact factor: 2.668

8.  Signal transducer and activation of transcription (STAT) 4beta, a shorter isoform of interleukin-12-induced STAT4, is preferentially activated by estrogen.

Authors:  Ebru Karpuzoglu; Rebecca A Phillips; Rujuan Dai; Carmine Graniello; Robert M Gogal; S Ansar Ahmed
Journal:  Endocrinology       Date:  2008-11-06       Impact factor: 4.736

9.  Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements.

Authors:  Sylvia C Hewitt; Yin Li; Leping Li; Kenneth S Korach
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

10.  Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.

Authors:  K C Leung; N Doyle; M Ballesteros; K Sjogren; C K W Watts; T H Low; G M Leong; R J M Ross; K K Y Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.